Browse resources

Region: North America and Europe

Total results with these characteristics: 157

Page 6 of 7  
‹ prev.
3
4
5
6
7
next ›

Respiratory Virus Immunization: A Field Trial of Two Inactivated Respiratory Virus Vaccines; an Aqueous Trivalent Parainfluenza Virus Vaccine and an Alum-Precipitated Respiratory Syncytial Virus Vaccine

This article, published in the American Journal of Epidemiology, describes a field trial conducted to evaluate an inactivated, alum-precipitated respiratory syncytial virus (RSV) vaccine and an aqueous trivalent parainfluenza virus vaccine. Study …

Author: Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G

Published: 1969

Risk and Protective Factors for Meningococcal Disease in Adolescents: Matched Cohort Study

This article, published in The British Medical Journal, discusses a study examining biological and social risk factors for meningococcal disease in adolescents in six regions of England. The study finds that significant independent risk factors …

Author: Tully J, Viner RM, Coen PG, et al.

Published: 2006

Risk of Guillain-Barré Syndrome After Meningococcal Conjugate Vaccination

A meningococcal conjugate vaccine (MCV4) was introduced in the United States in 2005. Shortly after, case reports of Guillain-Barré syndrome (GBS), a serious demyelinating disease, began to be reported to the Vaccine Adverse Event Reporting …

Author: Velentgas P, Amato AA, Bohn RL, et al.

Published: 2012

Risk of Intussusception after Monovalent Rotavirus Vaccination

This article, published in the New England Journal of Medicine, reports on a study that examined the risk of intussusception after monovalent rotavirus vaccination in a population in the United States. In this prospective postlicensure study of more …

Author: Weintraub ES, Baggs J, Duffy J, et al.

Published: 2014

Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants

This article, published in the Journal of the American Medical Association, reports on a study that examined the rates of intussusception in  infants in the United States during the 1- to 7-day and 1- to 30-day windows following vaccination …

Author: Shui IM, Baggs J, Patel M, et al.

Published: 2012

RotaShield® Vaccine and Intussusception Q&A

This fact sheet was developed to answer common questions about RotaShield® and the decision of the US Advisory Committee on Immunization Practices to suspend its recommendation for use.

Author: US Centers for Disease Control and Prevention

Published: 2004

Rotavirus Vaccination in Europe: Drivers and Barriers

This review article, published in The Lancet Infectious Diseases, presents an overview of the status of rotavirus vaccination in Europe. The authors discuss the drivers (including high effectiveness of the vaccines and the effect of universal …

Author: Parez N, Giaquinto C, Du Roure C, et al.

Published: 2014

Rotavirus Vaccine: What You Need to Know

Basic information on rotavirus vaccines and their addition to the US routine immunization schedule.

Author: US Centers for Disease Control and Prevention

Published: 2006

Rotavirus Vaccines and Health Care Utilization for Diarrhea in the United States (2007–2011)

This article, published in Pediatrics, reports on a study that examined reductions in diarrhea-associated health care utilization after rotavirus vaccine implementation in the United States (US) in order to assess direct and indirect effectiveness …

Author: Leshem E, Moritz RE, Curns AT, et al.

Published: 2014

Rotavirus-Associated Hospitalization and Emergency Department Costs and Rotavirus Vaccine Program Impact

The New Vaccine Surveillance Network began conducting surveillance for the economic burden of rotavirus in three counties in the United States (Hamilton County, Ohio; Davidson County, Tennessee; and Monroe County, New York) in 2006 and continued …

Author: Kilgore A, Donauer S, Edwards KM, et al.

Published: 2013

Routine Laboratory Testing Data for Surveillance of Rotavirus Hospitalizations to Evaluate the Impact of Vaccination

Researchers used laboratory and hospital data of children admitted to two US hospitals with acute gastroenteritis to assess the need for routine rotavirus testing and determine disease burden. Findings confirmed the need for continued surveillance …

Author: Patel MM, Tate JE, Selvarangan R, et al.

Published: 2007

Safety and Immunogenicity of ASO3(B) Adjuvanted Split Virion Versus Non-adjuvanted Whole Virion H1N1 Influenza Vaccine in UK Children Aged 6 Months-12 Years: Open Label, Randomised, Parallel Group, Multicentre Study

This article, published through Online First of the British Medical Journal, details a study wherein researchers evaluated the safety, tolerability, and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus …

Author: Waddington CS, Walker WT, Oeser C, et al.

Published: 2010

Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review

This article, published in Pediatrics, reviews the existing literature on the safety of routine vaccines recommended for children in the United States. The authors found evidence that some vaccines are associated with serious adverse events; …

Author: Maglione MA, Das L, Raaen L, et al.

Published: 2014

Setting the Immunization Agenda Through Advocacy and Communication

This document reports on a high-level meeting about setting the immunization agenda through advocacy and communication, held in London in January 2008. The meeting was held jointly by the United Kingdom Department of Health and the World Health …

Author: World Health Organization

Published: 2008

Single-Dose or Multi-Dose?

The reuse of single-dose vials and misuse of multiple-dose vials can result in patients suffering significant harm and even death. This dynamic infographic can help healthcare professionals learn the differences between single-dose and multiple-dose …

Author: US Centers for Disease Control and Prevention; Safe Injection Practices Coalition

Published: 2013

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

This article, published in The Journal of Infectious Diseases, discusses a study examining invasive pneumococcal disease (IPD) cases from 1998 to 2007 from eight sites across the United States to assess the impact of 7-valent …

Author: Pilishvili T, Lexau C, Farley MM, et al.

Published: 2010

Thimerosal

This web page provides a US Centers for Disease Control and Prevention (CDC) statement on the safety of thimerosal in vaccines and links to CDC and outside resources that provide further information on this topic. 

Author: US Centers for Disease Control and Prevention

Trends in Intussusception Hospitalizations Among US Infants Before and After Implementation of the Rotavirus Vaccination Program, 2000-2009

This article, published in the Journal of Infectious Diseases, reports on surveillance conducted following rotavirus vaccine introduction in 2006 that noted a small increase in intussusception among US infants aged 8 to 11 weeks, who would have …

Author: Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD

Published: 2012

Trends in National Rotavirus Activity Before and After Introduction of Rotavirus Vaccine into the National Immunization Program in the United States, 2000 to 2012

Rotavirus vaccine introduction in the United States in 2006 led to substantial declines in rotavirus detections during 2007 to 2010. To further evaluate the long-term impact of the vaccine program, the authors of this article, published in the …

Author: Tate JE, Haynes A, Payne DC, et al.

Published: 2013

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine

This article, published by The New England Journal of Medicine, details the findings of a single-center study in the United Kingdom to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine, in both MF59-adjuvanted and …

Author: Clark TW, Pareek M, Hoschler K, et al.

Published: 2009

Trial of Influenza A(H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine -- Preliminary Report

This article, published in The New England Journal of Medicine, describes the methods, results, and conclusions from a single-center study to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine. The study, conducted in the …

Author: Clark TW, Pareek M, Hoschler K, et al.

Published: 2009

Understanding Thimerosal, Mercury, and Vaccine Safety

This fact sheet explains what thimerosal is and why it is used as a preservative in some multi-dose vials of influenza vaccine, and highlights conclusions from studies examining thimerosal safety in vaccines.

Author: US Centers for Disease Control and Prevention

Published: 2012

US Centers for Disease Control and Prevention

The CDC's mission is to promote health and quality of life by preventing and controlling disease, injury, and disability.

Author: US Centers for Disease Control and Prevention (CDC)

Vaccinate Your Baby

This awareness campaign was launched by Every Child by Two, an organization devoted to raising awareness of the critical need for timely immunization and to foster a systematic way to immunize all of America's children by age two. This campaign's …

Author: Every Child by Two

Vaccine Information Statements

Vaccine Information Statements (VISs) are information sheets used in the United States (US) that explain both the benefits and risks of a vaccine to vaccine recipients. US federal law requires that healthcare staff provide a VIS to a patient, …

Author: US Centers for Disease Control and Prevention

Page 6 of 7  
‹ prev.
3
4
5
6
7
next ›